CAI Earnings & Financial Statements
Caris Life Sciences, Inc.
$29.53
-$0.16(-0.54%)
75
Overall
60
Value
91
Tech
76
Quality
Market Cap
$8.39B
Volume
3.52M
52W Range
$14.19 - $33.65
Target Price
$28.92
CAI earnings and financial statements: Caris Life Sciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CAI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $812.03M | $412.26M | $306.13M |
| Cost of revenue | - | $233.48M | $216.82M |
| Operating income | -$66.46M | -$257.47M | -$332.16M |
| EBITDA | $29.73M | -$212.87M | -$255.43M |
| Net income | -$127.37M | -$318.86M | -$341.42M |
| EPS (diluted) | $-3.22 | $-10.66 | $-13.24 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $327.86M | $343.73M | $412.90M |
| Total liabilities | $548.36M | $620.92M | $432.57M |
| Shareholders’ equity | $577.31M | $1.94B | -$19.67M |
| Cash and equivalents | - | $65.44M | $60.01M |
| Long-term debt | $378.82M | $319.44M | $166.42M |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | $30.87M | -$245.20M | -$276.10M |
| Capital expenditure | -$16.26M | - | - |
| Free cash flow | $66.89M | -$253.64M | -$298.42M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CAI | $29.53 | -0.5% | 3.52M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Caris Life Sciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW